Green Cures & Botanical Distribution Inc.
Green Cures & Botanical Distribution Inc.
Your view on GRCU
Overview
What the company does, where it operates, and who runs it.
About Green Cures & Botanical Distribution Inc.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Rich Thomas
- Headquarters
- 11222 S La Cienega Boulevard, Denver, CA, US
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- CEO
- Rich Thomas
- Headquarters
- 11222 S La Cienega Boulevard, Denver, CA, US
Green Cures & Botanical Distribution Inc. operates various services and products in the medical marijuana and botanical industry. It focuses on the production, distribution, and management of cannabis-derived products.
The company's products comprise nutritional supplements, vitamins, minerals, herbs/botanicals, sports nutrition, and specialty products. It also provides online community portals that supply public with information and resources regarding the benefits of cannabis-derived products.
Green Cures & Botanical Distribution Inc. is based in Inglewood, California.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Green Cures & Botanical Distribution Inc., and the rating behind it. GRCU last traded at $0.0001; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Green Cures & Botanical Distribution Inc.. Starting points for Green Cures & Botanical Distribution Inc.: beta 10.00 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Green Cures & Botanical Distribution Inc.. Green Cures & Botanical Distribution Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Green Cures & Botanical Distribution Inc.. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Green Cures & Botanical Distribution Inc.. Green Cures & Botanical Distribution Inc. has reported as a listed company since 2005. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Green Cures & Botanical Distribution Inc. valued side by side against its closest peers. Green Cures & Botanical Distribution Inc. is measured against Drug Manufacturers - Specialty & Generic peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Green Cures & Botanical Distribution Inc., and how their positions are changing. At a $783,949 market value, institutional positions materially move Green Cures & Botanical Distribution Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Green Cures & Botanical Distribution Inc. executives and directors. Shares of Green Cures & Botanical Distribution Inc. have traded between $0.0001 and $0.0002 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Green Cures & Botanical Distribution Inc.. Green Cures & Botanical Distribution Inc. is a $783,949 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Green Cures & Botanical Distribution Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Green Cures & Botanical Distribution Inc.. Coverage tracks Green Cures & Botanical Distribution Inc. within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.